Literature DB >> 19929690

Mortality associated with Acinetobacter baumannii complex bacteremia among patients with war-related trauma.

Grace Kang1, Joshua D Hartzell, Robin Howard, Robert N Wood-Morris, Mark D Johnson, Susan Fraser, Amy Weintrob, Glenn Wortmann.   

Abstract

We investigated the mortality associated with Acinetobacter baumannii complex bacteremia among a cohort of patients hospitalized for war-related trauma. Despite a high prevalence of multidrug-resistant strains, the 30-day mortality rate was 2%. For relatively young patients with war-related trauma, A. baumannii complex bacteremia appears to be associated with a low risk of death.

Entities:  

Mesh：

Year:  2010        PMID： 19929690     DOI： 10.1086/649220

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  10 in total

1.  Trauma is associated with a better prognosis in intensive care patients with Acinetobacter infections.

Authors:  A C Tonacio; M S Oliveira; L M S Malbouisson; A S Levin
Journal:  Infection       Date:  2013-10-30       Impact factor: 3.553

2.  Morphine, but not trauma, sensitizes to systemic Acinetobacter baumannii infection.

Authors:  Jessica M Breslow; M Alexandra Monroy; John M Daly; Joseph J Meissler; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-09       Impact factor: 4.147

3.  After the Battlefield: Infectious Complications among Wounded Warriors in the Trauma Infectious Disease Outcomes Study.

Authors:  David R Tribble; Clinton K Murray; Bradley A Lloyd; Anuradha Ganesan; Katrin Mende; Dana M Blyth; Joseph L Petfield; Jay McDonald
Journal:  Mil Med       Date:  2019-11-01       Impact factor: 1.437

4.  Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities.

Authors:  Galarah D Golanbar; Christopher K Lam; Yi-Ming Chu; Carla Cueva; Stephanie W Tan; Isba Silva; H Howard Xu
Journal:  J Clin Microbiol       Date:  2011-03-30       Impact factor: 5.948

Review 5.  Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.

Authors:  J Alexander Viehman; M Hong Nguyen; Yohei Doi
Journal:  Drugs       Date:  2014-08       Impact factor: 9.546

6.  Severe Acinetobacter baumannii sepsis is associated with elevation of pentraxin 3.

Authors:  Patrick M Ketter; M Neal Guentzel; Beverly Schaffer; Maryanne Herzig; Xiaowu Wu; Robbie K Montgomery; Bijaya K Parida; Chriselda G Fedyk; Jieh-Juen Yu; James Jorgensen; James P Chambers; Andrew P Cap; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2014-07-07       Impact factor: 3.441

Review 7.  Systematic review and meta-analysis of the proportion and associated mortality of polymicrobial (vs monomicrobial) pulmonary and bloodstream infections by Acinetobacter baumannii complex.

Authors:  Stamatis Karakonstantis; Evangelos I Kritsotakis
Journal:  Infection       Date:  2021-07-14       Impact factor: 3.553

8.  Genome Sequences of Four Acinetobacter baumannii-A. calcoaceticus Complex Isolates from Combat-Related Infections Sustained in the Middle East.

Authors:  Patrick Ketter; M Neal Guentzel; James P Chambers; James Jorgensen; Clinton K Murray; Andrew P Cap; Jieh-Juen Yu; Mark Eppinger; Bernard P Arulanandam
Journal:  Genome Announc       Date:  2014-02-06

9.  Molecular characterization and antimicrobial susceptibility of Acinetobacter baumannii isolates obtained from two hospital outbreaks in Los Angeles County, California, USA.

Authors:  Wayne A Warner; Shan N Kuang; Rina Hernandez; Melissa C Chong; Peter J Ewing; Jen Fleischer; Jia Meng; Sheena Chu; Dawn Terashita; L'Tanya English; Wangxue Chen; H Howard Xu
Journal:  BMC Infect Dis       Date:  2016-05-04       Impact factor: 3.090

10.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter Baumannii Complex Isolates from Patients that were Injured During the Eastern Ukrainian Conflict.

Authors:  Heike Granzer; Ralf Matthias Hagen; Philipp Warnke; Wolfgang Bock; Tobias Baumann; Norbert Georg Schwarz; Andreas Podbielski; Hagen Frickmann; Thomas Koeller
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-05-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.